Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Cited In for PubMed (Select 17156941)

1.

Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P.

Xu J, Xu M, Bolan E, Gilbert AK, Pasternak GW, Pan YX.

Synapse. 2014 Apr;68(4):144-52. doi: 10.1002/syn.21727. Epub 2014 Jan 16.

2.

Mu opioids and their receptors: evolution of a concept.

Pasternak GW, Pan YX.

Pharmacol Rev. 2013 Sep 27;65(4):1257-317. doi: 10.1124/pr.112.007138. Print 2013. Review.

3.

Opioids and their receptors: Are we there yet?

Pasternak GW.

Neuropharmacology. 2014 Jan;76 Pt B:198-203. doi: 10.1016/j.neuropharm.2013.03.039. Epub 2013 Apr 26. Review.

4.

Opioid sensitivity in mice selectively bred to consume or not consume methamphetamine.

Eastwood EC, Phillips TJ.

Addict Biol. 2014 May;19(3):370-9. doi: 10.1111/adb.12003. Epub 2012 Nov 12.

PMID:
23145527
5.

Elucidation of mu-Opioid Gene Structure: How Genetics Can Help Predict Responses to Opioids.

Diatchenko L, Robinson JE, Maixner W.

Eur J Pain Suppl. 2011 Nov 11;5(2):433-438.

6.

Identification and characterization of seven new exon 11-associated splice variants of the rat μ opioid receptor gene, OPRM1.

Xu J, Xu M, Rossi GC, Pasternak GW, Pan YX.

Mol Pain. 2011 Jan 21;7:9. doi: 10.1186/1744-8069-7-9.

7.

Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder.

Garriock HA, Tanowitz M, Kraft JB, Dang VC, Peters EJ, Jenkins GD, Reinalda MS, McGrath PJ, von Zastrow M, Slager SL, Hamilton SP.

Am J Psychiatry. 2010 May;167(5):565-73. doi: 10.1176/appi.ajp.2009.08081167. Epub 2010 Mar 1.

8.

Identification of candidate genes and gene networks specifically associated with analgesic tolerance to morphine.

Tapocik JD, Letwin N, Mayo CL, Frank B, Luu T, Achinike O, House C, Williams R, Elmer GI, Lee NH.

J Neurosci. 2009 Apr 22;29(16):5295-307. doi: 10.1523/JNEUROSCI.4020-08.2009.

9.

Expansion of the human mu-opioid receptor gene architecture: novel functional variants.

Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, Shibata K, Tchivileva IE, Belfer I, Mishra B, Kiselycznyk C, Wallace MR, Staud R, Spiridonov NA, Max MB, Goldman D, Fillingim RB, Maixner W, Diatchenko L.

Hum Mol Genet. 2009 Mar 15;18(6):1037-51. doi: 10.1093/hmg/ddn439. Epub 2008 Dec 22.

10.

Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene.

Xu J, Xu M, Hurd YL, Pasternak GW, Pan YX.

J Neurochem. 2009 Feb;108(4):962-72. doi: 10.1111/j.1471-4159.2008.05833.x. Epub 2008 Dec 10.

11.

Increased adiposity on normal diet, but decreased susceptibility to diet-induced obesity in mu-opioid receptor-deficient mice.

Zuberi AR, Townsend L, Patterson L, Zheng H, Berthoud HR.

Eur J Pharmacol. 2008 May 6;585(1):14-23. doi: 10.1016/j.ejphar.2008.01.047. Epub 2008 Feb 26.

12.

Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.

Doyle GA, Sheng XR, Lin SS, Press DM, Grice DE, Buono RJ, Ferraro TN, Berrettini WH.

Gene. 2007 Jun 15;395(1-2):98-107. Epub 2007 Feb 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk